Chimerix is now part of Jazz Pharmaceuticals. Learn more at www.jazzpharma.com

ONC206 Publications

onc206

IND-enabling characterization of dual DRD2-and ClpP-targeting agent ONC206 as the next imipridone for clinical neuro-oncology

Neuro-Oncology 2020

Prabhu V, Morrow S, Kawakibi AR, et al.

onc206

Predictive biomarker evaluation and molecular differentiation for imipridones ONC201 and ONC206

AACR annual meeting 2021, Abstract Number: 393

Morrow S, Nath K, Zhang Y, et al.

onc206

Targeting dopamine receptor D2 by imipridone suppresses uterine serous cancer malignant phenotype

Cancers (Basel). 2020 PMID: 32867127

Hu W, Zhang L, Ferri-Borgogno S, et al.